Pfizer said Tuesday it will provide UNICEF with up to 4 million doses of its COVID-19 treatment Paxlovid to be distributed among low- and middle-income countries

An expert committee at the Japanese Health Ministry has cleared Pfizer/BioNTech's oral drug for COVID-19 Paxlovid, making it the second such treatment allowed in the country, the ministry said on Thursday

The European Medicines Agency's (EMA) human medicines committee (CHMP) recommended a conditional marketing authorization for Paxlovid, the first oral medicine for treating COVID-19 in at risk adult populations, Marco Cavaleri, the head of Biological Health Threats and Vaccines Strategy at the EMA, said on Thursday

The European Medicines Agency (EMA) on Thursday recommended a conditional marketing authorization for Paxlovid, the first oral medicine for treating COVID-19